GILEAD SCIENCES, INC. Total Liabilities 2008-2026 | GILD
Beta
What is total liabilities?
Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.
What is GILEAD SCIENCES, INC.'s current total liabilities?
GILEAD SCIENCES, INC. (GILD) annual total liabilities for 2025 was $36.41B, a 8.41% decline from 2024. GILEAD SCIENCES, INC. total liabilities for the quarter ending March 31, 2026 was $32.85B.
What was GILEAD SCIENCES, INC.'s total liabilities in 2024?
GILEAD SCIENCES, INC. annual total liabilities for 2024 was $39.75B, a 0.95% increase from 2023.
What was GILEAD SCIENCES, INC.'s total liabilities in 2023?
GILEAD SCIENCES, INC. annual total liabilities for 2023 was $39.38B, a 6.16% decline from 2022.
What is GILEAD SCIENCES, INC.'s 5-year total liabilities CAGR?
GILEAD SCIENCES, INC. total liabilities grew at a compound annual growth rate (CAGR) of 6.22% from FY2020 to FY2025, going from $50.19B to $36.41B over 5 years.
Total Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-6.2%
FY2020
$50.19B
→
FY2025
$36.41B
080910111213141516171819202122232425
5 years selected
Total Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $36.41B | -8.4% | 10-K |
| FY2024 | $39.75B | +0.9% | 10-K |
| FY2023 | $39.38B | -6.2% | 10-K |
| FY2022 | $41.96B | -10.5% | 10-K |
| FY2021 | $46.89B | -6.6% | 10-K |
| FY2020 | $50.19B | +28.8% | 10-K |
| FY2019 | $38.98B | -7.5% | 10-K |
| FY2018 | $42.14B | -15.3% | 10-K |
| FY2017 | $49.78B | +32.3% | 10-K |
| FY2016 | $37.61B | +15.4% | 10-K |
| FY2015 | $32.60B | +73.0% | 10-K |
| FY2014 | $18.84B | +73.9% | 10-K |
| FY2013 | $10.83B | -7.4% | 10-K |
| FY2012 | $11.70B | +12.1% | 10-K |
| FY2011 | $10.44B | +90.8% | 10-K |
| FY2010 | $5.47B | +71.3% | 10-K |
| FY2009 | $3.19B | +29.2% | 10-K |
| FY2008 | $2.47B | - | 10-K |
Company: GILEAD SCIENCES, INC.Ticker: GILDSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →